Go to main content
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS

Linked e-resources

Details

Intro
Copyright
Introduction: The GIDEON e-book series
Table of Contents
COVID-19
Epidemiology
Agent
Reservoir
Vector
Vehicle
Incubation Period
Diagnostic Tests
Typical Adult Therapy
Typical Pediatric Therapy
Vaccines
Clinical Hints
Synonyms
References
Clinical
References
Distribution Map
Images
Global status
References
Afghanistan
References
Albania
References
Algeria
References
American Samoa
References
Andorra
References
Angola
References
Anguilla
References
Antigua and Barbuda
References
The Antilles (miscellaneous)
References
Argentina
References
Armenia
References
Aruba
References
Australia
References
Austria
References
Azerbaijan
References
The Azores
References
The Bahamas
References
Bahrain
References
Bangladesh
References
Barbados
References
Belarus
References
Belgium
References
Belize
References
Benin
References
Bermuda
References
Bhutan
References
Bolivia
References
Bosnia and Herzegovina
References
Botswana
References
Brazil
References
The British Virgin Islands
References
Brunei
References
Bulgaria
References
Burkina Faso
References
Burundi
References
Cambodia
References
Cameroon
References
Canada
References
The Canary Islands
References
Cape Verde
References
The Cayman Islands
References
Central African Republic
References
Chad
References
Chile
References
China
References
Colombia
References
The Comoros and Mayotte
References
Congo
References
The Cook Islands
References
Costa Rica
References
Croatia
References
Cuba
References
Cyprus
References.

The Czech Republic
References
The Democratic Republic of Congo
References
Denmark
References
Djibouti
References
Dominica
References
The Dominican Republic
References
Ecuador
References
Egypt
References
El Salvador
References
Equatorial Guinea
References
Eritrea
References
Estonia
References
Eswatini
References
Ethiopia
References
The Falkland Islands
References
Fiji
References
Finland
References
France
References
French Guiana
References
French Polynesia
References
Gabon
References
Gambia
References
Georgia
References
Germany
References
Ghana
References
Gibraltar
References
Greece
References
Greenland
References
Grenada
References
Guadeloupe
References
Guam
References
Guatemala
References
Guinea
References
Guinea Bissau
References
Guyana
References
Haiti
References
Honduras
References
Hong Kong
References
Hungary
References
Iceland
References
India
References
Indonesia
References
Iran
References
Iraq
References
Ireland
References
Israel
References
Italy
References
Ivory Coast
References
Jamaica
References
Japan
References
Jordan
References
Kazakhstan
References
Kenya
References
Kiribati
References
Kosovo
References
Kuwait
References
Kyrgyzstan
References
Laos
References
Latvia
References
Lebanon
References
Lesotho
References
Liberia
References
Libya
References
Liechtenstein
References
Lithuania
References
Luxembourg
References
Macao
References
Madagascar
References
Malawi
References
Malaysia
References
The Maldives
References
Mali.

References
Malta
References
The Marshall Islands
References
Martinique
References
Mauritania
References
Mauritius
References
Mexico
References
Micronesia
References
Moldova
References
Monaco
References
Mongolia
References
Montenegro
References
Montserrat
References
Morocco
References
Mozambique
References
Myanmar
References
Namibia
References
Nauru
Nepal
References
The Netherlands
References
New Caledonia
References
New Zealand
References
Nicaragua
References
Niger
References
Nigeria
References
Niue
References
North Macedonia
References
Northern Ireland
References
The Northern Marianas
References
Norway
References
Oman
References
Pakistan
References
Palau
References
Panama
References
Papua New Guinea
References
Paraguay
References
North Korea
References
Peru
References
The Philippines
References
Pitcairn Island
Poland
References
Portugal
References
Puerto Rico
References
Qatar
References
South Korea
References
Reunion
References
Romania
References
The Russian Federation
References
Rwanda
References
Samoa
References
San Marino
References
Sao Tome and Principe
References
Saudi Arabia
References
Scotland
References
Senegal
References
Serbia
References
The Seychelles
References
Sierra Leone
References
Singapore
References
Slovakia
References
Slovenia
References
The Solomon Islands
References
Somalia
References
South Africa
References
South Sudan
References
Spain
References
Sri Lanka
References
St. Helena
References
Saint Kitts and Nevis
References.

Saint Lucia
References
Saint Vincent and The Grenadines
References
Sudan
References
Suriname
References
Sweden
References
Switzerland
References
Syria
References
Taiwan
References
Tajikistan
References
Tanzania
References
Thailand
References
Timor-Leste
References
Togo
References
Tokelau
Tonga
References
Trinidad and Tobago
References
Tunisia
References
Turkey
References
Turkmenistan
References
The Turks and Caicos Islands
References
Tuvalu
Uganda
References
Ukraine
References
The United Arab Emirates
References
The United Kingdom
References
The United States
References
Uruguay
References
Uzbekistan
References
Vanuatu
References
Venezuela
References
Vietnam
References
The U.S. Virgin Islands
References
Wallis and Futuna Islands
References
Western Sahara
References
Yemen
References
Zambia
References
Zimbabwe
References
Vaccines &
Immunoglobulins
Bamlanivimab
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for Bamlanivimab (2 listed)
Contraindications for Bamlanivimab (0 listed)
Trade names of Bamlanivimab (3 listed)
Bebtelovimab
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for Bebtelovimab (5 listed)
Contraindications for Bebtelovimab (0 listed)
Trade names of Bebtelovimab (1 listed)
Bimervax
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for Bimervax (6 listed)
Contraindications for Bimervax (2 listed)
Trade names of Bimervax (1 listed)
Casirivimab / Imdevimab
Mechanism of Action.

Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for Casirivimab / Imdevimab (6 listed)
Contraindications for Casirivimab / Imdevimab (1 listed)
Trade names of Casirivimab / Imdevimab (2 listed)
COVID-19 - inactivated vaccine
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for COVID-19 - inactivated vaccine (13 listed)
Contraindications for COVID-19 - inactivated vaccine (2 listed)
Trade names of COVID-19 - inactivated vaccine (14 listed)
COVID-19 - mRNA vaccine
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for COVID-19 - mRNA vaccine (16 listed)
Contraindications for COVID-19 - mRNA vaccine (1 listed)
Trade names of COVID-19 - mRNA vaccine (8 listed)
COVID-19 - recombinant nanoparticle vaccine
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for COVID-19 - recombinant nanoparticle vaccine (7 listed)
Contraindications for COVID-19 - recombinant nanoparticle vaccine (2 listed)
Trade names of COVID-19 - recombinant nanoparticle vaccine (10 listed)
COVID-19 - viral vector vaccine
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for COVID-19 - viral vector vaccine (11 listed)
Contraindications for COVID-19 - viral vector vaccine (1 listed)
Trade names of COVID-19 - viral vector vaccine (14 listed)
Pemivibart
Mechanism of Action
Typical Adult Dosage
Typical Pediatric Dosage
Subsequent booster
Toxic Effects for Pemivibart (2 listed)
Contraindications for Pemivibart (1 listed)
Trade names of Pemivibart (1 listed)
Regdanvimab
Mechanism of Action
Typical Adult Dosage.

Typical Pediatric Dosage.

Browse Subjects

Show more subjects...

Statistics

from
to
Export